Urine test may replace needle biopsy for kidney transplant patients
NCT ID NCT01380847
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a simple urine test could predict scarring in kidney transplants, instead of using a needle biopsy. Researchers measured certain genetic markers in urine cells from 300 kidney transplant recipients over the first year after transplant. The goal was to see if these markers could forecast kidney damage early, helping doctors intervene sooner.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC ALLOGRAFT NEPHROPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Necker Hospital
Paris, 75015, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could your bone health decide if a dental implant lasts?
- Can a new drug work safely in patients with kidney failure?
- Can a simple foot pump ease leg swelling in hospital patients?
- Could your blood type predict kidney treatment success?
- Can community hospitals in zambia master severe disease care?
- Can an ancient herbal remedy soothe the aftermath of stone surgery?